J. S. Hans Vles

J. S. Hans Vles

Auto-generated profile, based on publicly available information

J. S. Hans Vles

School for Mental Health and NeuroScience, Maastricht University, Maastricht, The Netherlands

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 December 2020 in Pediatric Cardiology
Verified
Journal Article
Open access
PDF file
MBMelinda Barkhuizen
Melinda Barkhuizen
RARaul Abella
Raul Abella
JVJ. S. Hans Vles
J. S. Hans Vles
LZLuc J.I. Zimmermann
Luc J.I. Zimmermann
DGDiego Gazzolo
Diego Gazzolo
DGDanilo AW Gavilanes
Danilo AW Gavilanes
Congenital heart defects (CHD) is one of the most common types of birth defects. Thanks to advances in surgical techniques and intensive care, the majority of children with severe forms of CHD survive into adulthood. However, this increase in survival comes with a cost. CHD survivors have neurological functioning at the bottom of the normal range. A large spectrum of central nervous system dysmaturation leads to the deficits seen in critical CHD. The heart develops early during gestation, and CHD has a profound effect on fetal brain development for the remainder of gestation. Term infants with critical CHD are born with an immature brain, which is highly susceptible to hypoxic-ischemic injuries. Perioperative blood flow disturbances due to the CHD and the use of cardiopulmonary bypass or circulatory arrest during surgery cause additional neurological injuries. Innate patient factors, such as genetic syndromes and preterm birth, and postoperative complications play a larger role in neurological injury than perioperative factors. Strategies to reduce the disability burden in critical CHD survivors are urgently needed.

22 September 2016 in JMIR Serious Games
Verified
Journal Article
Open access
JPJanneke Caw Peijnenborgh
Janneke Caw Peijnenborgh
PHPetra Hurks
Petra Hurks
AAAlbert P Aldenkamp
Albert P Aldenkamp
ESErik D. van der Spek
Erik D. van der Spek
GRGwm Rauterberg
Gwm Rauterberg
JHJos Gm Hendriksen
Jos Gm Hendriksen
A multidisciplinary journal on gaming and gamification for health education/promotion, teaching and social change.

1 May 2007 in Developmental Medicine & Child Neurology
Verified
Journal Article
Closed access
PDF file
MHM A Hoving
M A Hoving
SES M A A Evers
S M A A Evers
AAA J H A Ament
A J H A Ament
ERE P M Van Raak
E P M Van Raak
JVJ S H Vles
J S H Vles
OSOn behalf of the Dutch Group on Child Spasticity
On behalf of the Dutch Group on Child Spasticity

1 September 1993 in Pediatric Research
Verified
Journal Article
Open access
PDF file
HHHarmen H De Haan
Harmen H De Haan
JRJos L H Van Reempts
Jos L H Van Reempts
MBMarcel Borgers
Marcel Borgers
JHJelte De Haan
Jelte De Haan
JVJohan S H Vles
Johan S H Vles
THTom H M Hasaart
Tom H M Hasaart
Neuroprotective properties of the calcium channel blocker flunarizine have been reported after hypoxic-ischemic insults in immature, infant, and adult rats. However, its effect on fetal regional cerebral blood flow (rCBF) and systemic blood pressure after severe asphyxia is not known. In 15 fetal lambs (3 to 5 d after surgery; gestational age at the experiment, 123.2 ± 2.5 d), arterial oxygen content was progressively reduced to 30% by restriction of uterine blood flow with an inflatable balloon occluder around the maternal common internal iliac artery. The rCBF was measured with radioactive microspheres at baseline condition, after 1 h of severe asphyxia, and at 30 and 120 min in the recovery phase. Immediately after the end of the occlusion period, fetuses randomly received either flunarizine or its solvent (0.5 mg/kg estimated fetal weight). No differences in rCBF changes between groups were observed during and after asphyxia. Changes in arterial blood pressure or fetal heart rate due to flunarizine could not be demonstrated either. Only five fetuses (33%) survived this degree of asphyxia longer than 24 h: four of the flunarizine-treated group and one of the control group. It is unlikely that this possible protective property of the drug is caused by its influence on rCBF, arterial blood pressure, or fetal heart rate in the phase immediately after asphyxia.

1 June 1993 in Developmental Medicine & Child Neurology
Verified
Journal Article
Closed access
PDF file
VKV. H. J. M. van Kranen‐Mastenbroek
V. H. J. M. van Kranen‐Mastenbroek
KFK. B. Folmer
K. B. Folmer
Herman KingmaHerman Kingma
Herman Kingma
HCH. Caberg
H. Caberg
CBC. E. Blanco
C. E. Blanco
JVJ. S. H. Vles
J. S. H. Vles

1 February 2015 in CNS & Neurological Disorders - Drug Targets
Verified
Journal Article
Closed access
PDF file
MNMaria Nikiforou
Maria Nikiforou
EVEvi Vlassaks
Evi Vlassaks
ESEveline Strackx
Eveline Strackx
BKBoris W. Kramer
Boris W. Kramer
JVJohan S.H. Vles
Johan S.H. Vles
DGDanilo AW Gavilanes
Danilo AW Gavilanes
Hypoxic-ischemic preconditioning (HIPC) has a neuroprotective effect against a subsequent, more severe perinatal hypoxic-ischemic episode. The protective processes of preconditioning (PC) in the immature brain remain undefined but are most likely related to the immune cells of the central nervous system. To determine the role of astrocytes in HIPC, we initially exposed primary rat astrocytes to oxygen-glucose deprivation (OGD) for 30 minutes as a PC stimulus. A subsequent more severe insult was induced 24 hours later by exposing the astrocytes to OGD for 3 hours. These experiments revealed that OGD for 3 hours induced increased cytotoxicity as measured by lactate dehydrogenase in primary astrocytes, which was diminished in astrocytes earlier subjected to PC. Moreover, decreased cell proliferation, as measured by Ki67, and lower cytokine expression (IL-1β, TNF-α, IL-6, IL-10) were observed in astrocytes subjected to OGD for 3 hours, while these levels remained unchanged in PC+OGD cells. Therefore, we speculate that PC by OGD may affect the survival, proliferation and function of primary cultured astrocytes which may partly explain the neuroprotective properties of HIPC seen in HI rat models.